Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast CancerDavide Mauri, John P. A. Ioannidis, Nikolaos P. Polyzos et al.|JNCI Journal of the National Cancer Institute|2008Cited by 524
Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple TreatmentsMaria Kyrgiou, John P. A. Ioannidis, Georgia Salanti et al.|JNCI Journal of the National Cancer Institute|2006Cited by 182
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysisVassilis Golfinopoulos, John P. A. Ioannidis, Georgia Salanti et al.|The Lancet Oncology|2007Cited by 160
Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and BeyondStergios Boussios, Nicholas Pavlidis|Drugs in R&D|2020Cited by 138
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016Christian Dittrich, Rainer Kunstfeld, Fátima Cardoso et al.|ESMO Open|2016Cited by 129